SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-15-000387
Filing Date
2015-08-24
Accepted
2015-08-21 17:31:12
Documents
1
Group Members
ARCH VENTURE PARTNERS VI L.P.ARCH VENTURE PARTNERS VI LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 VBI VACCINES, INC. sch13d_17850.htm SC 13D/A 198653
  Complete submission text file 0001072613-15-000387.txt   200500
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Subject) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-41542 | Film No.: 151069573
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 8725 W HIGGINS RD STE 290 CHICAGO IL 60631
Business Address 8725 W HIGGINS RD STE 290 CHICAGO IL 60631 7733806600
ARCH VENTURE FUND VI LP (Filed by) CIK: 0001222135 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A